Zhejiang East Asia Pharmaceutical Co., Ltd. produces and sells pharmaceutical chemicals, tablets, granules, intermediates, and capsules. It offers quinolones synthetic antibacterial agents, antifungal products, gastrointestinal medications, semi-synthetic cephalosporin antibiotics, carbapenem antibiotics, antiviral agents, central nervous system medications, respiratory drugs, antiallergic agents, antineoplastic agents and tumor adjuvant drugs, and other products. The company provides products in the fields of cardiovascular, anti-aging dementia, digestive system, diabetic neuropathy, and anti-pathogenic microorganisms. It serves customers through a sales network in China, Europe, the United States, Southeast Asia, and internationally. The company was founded in 1992 and is headquartered in Taizhou, China.
Metrics to compare | 605177 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship605177PeersSector | |
---|---|---|---|---|
P/E Ratio | −17.6x | −9.9x | −0.5x | |
PEG Ratio | 0.08 | 0.02 | 0.00 | |
Price/Book | 1.2x | 3.8x | 2.6x | |
Price / LTM Sales | 2.2x | 4.8x | 3.2x | |
Upside (Analyst Target) | - | −10.8% | 42.0% | |
Fair Value Upside | Unlock | −14.1% | 6.6% | Unlock |